Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

You Sun Kim

Showing results (241-250 of 262) with videos related to

Pageof 27
Sort By:
Stem Cells and Development|March 13, 2015
The Therapeutic Effects of Human Mesenchymal Stem Cells Primed with Sphingosine-1 Phosphate on Pulmonary Artery HypertensionHyunsook Kang, Kang-Hyun Kim, Jisun Lim, et al.
Gut and Liver|September 26, 2019
Risk Factors for Postoperative Recurrence in Korean Patients with Crohn's DiseaseSung Bae Kim, Jae Hee Cheon, Jae Jun Park, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
Airway exposure levels of lipopolysaccharide determine type 1 versus type 2 experimental asthmaYoon-Keun Kim, Sun-Young Oh, Seong Gyu Jeon, et al.
Inflammatory Bowel Diseases|November 6, 2010
Prospective evaluation of the clinical utility of interferon-γ assay in the differential diagnosis of intestinal tuberculosis and Crohn's diseaseBeom Jin Kim, Yong Sung Choi, Byung Ik Jang, et al.
Inflammatory Bowel Diseases|May 25, 2013
Quantifying exposure to diagnostic radiation and factors associated with exposure to high levels of radiation in Korean patients with inflammatory bowel diseaseYoon Suk Jung, Dong Il Park, Eun Ran Kim, et al.
The New England Journal of Medicine|January 26, 2017
Bezlotoxumab for Prevention of Recurrent Clostridium difficile InfectionMark H Wilcox, Dale N Gerding, Ian R Poxton, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 18, 2011
Diagnostic utility of anti-Saccharomyces cerevisiae antibody (ASCA) and Interferon-γ assay in the differential diagnosis of Crohn's disease and intestinal tuberculosisYou Sun Kim, Young-Ho Kim, Won Ho Kim, et al.
Journal of Gastroenterology and Hepatology|July 9, 2013
Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis: a Korean multicenter retrospective studyKang-Moon Lee, Yoon Tae Jeen, Ju Yeon Cho, et al.
Inflammatory Bowel Diseases|January 27, 2021
Clinical Outcomes and Response Predictors of Vedolizumab Induction Treatment for Korean Patients With Inflammatory Bowel Diseases Who Failed Anti-TNF Therapy: A KASID Prospective Multicenter Cohort StudyJeongseok Kim, Hyuk Yoon, Nayoung Kim, et al.
Experimental & Molecular Medicine|March 5, 2024
SIRT1 ISGylation accelerates tumor progression by unleashing SIRT1 from the inactive state to promote its deacetylase activityJi An Kang, Yoon Jung Kim, Kyu Yun Jang, et al.
Pageof 27

Showing results (241-250 of 262) with videos related to

Sort By:
Pageof 27
Stem Cells and Development|March 13, 2015
The Therapeutic Effects of Human Mesenchymal Stem Cells Primed with Sphingosine-1 Phosphate on Pulmonary Artery HypertensionHyunsook Kang, Kang-Hyun Kim, Jisun Lim, et al.
Gut and Liver|September 26, 2019
Risk Factors for Postoperative Recurrence in Korean Patients with Crohn's DiseaseSung Bae Kim, Jae Hee Cheon, Jae Jun Park, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2007
Airway exposure levels of lipopolysaccharide determine type 1 versus type 2 experimental asthmaYoon-Keun Kim, Sun-Young Oh, Seong Gyu Jeon, et al.
Inflammatory Bowel Diseases|November 6, 2010
Prospective evaluation of the clinical utility of interferon-γ assay in the differential diagnosis of intestinal tuberculosis and Crohn's diseaseBeom Jin Kim, Yong Sung Choi, Byung Ik Jang, et al.
Inflammatory Bowel Diseases|May 25, 2013
Quantifying exposure to diagnostic radiation and factors associated with exposure to high levels of radiation in Korean patients with inflammatory bowel diseaseYoon Suk Jung, Dong Il Park, Eun Ran Kim, et al.
The New England Journal of Medicine|January 26, 2017
Bezlotoxumab for Prevention of Recurrent Clostridium difficile InfectionMark H Wilcox, Dale N Gerding, Ian R Poxton, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 18, 2011
Diagnostic utility of anti-Saccharomyces cerevisiae antibody (ASCA) and Interferon-γ assay in the differential diagnosis of Crohn's disease and intestinal tuberculosisYou Sun Kim, Young-Ho Kim, Won Ho Kim, et al.
Journal of Gastroenterology and Hepatology|July 9, 2013
Efficacy, safety, and predictors of response to infliximab therapy for ulcerative colitis: a Korean multicenter retrospective studyKang-Moon Lee, Yoon Tae Jeen, Ju Yeon Cho, et al.
Inflammatory Bowel Diseases|January 27, 2021
Clinical Outcomes and Response Predictors of Vedolizumab Induction Treatment for Korean Patients With Inflammatory Bowel Diseases Who Failed Anti-TNF Therapy: A KASID Prospective Multicenter Cohort StudyJeongseok Kim, Hyuk Yoon, Nayoung Kim, et al.
Experimental & Molecular Medicine|March 5, 2024
SIRT1 ISGylation accelerates tumor progression by unleashing SIRT1 from the inactive state to promote its deacetylase activityJi An Kang, Yoon Jung Kim, Kyu Yun Jang, et al.
Pageof 27